Ascendis Pharma A/S

ASNDNasdaq Denmark Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$15.049 B

$228.41 +1.04%

Close of 8 Oct 2026

As of 8 Oct 2026, Ascendis Pharma A/S (ASND) has a market capitalization of $15.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

61,977,408

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#23InsmedINSM$22.2B
#24ViatrisVTRS$20.1B
#25Ascendis Pharma A/SASND$15.0B
#26Jazz PharmaceuticalsJAZZ$15.0B
#27Summit TherapeuticsSMMT$14.4B

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Ascendis Pharma A/S, worth $492.7K. Grants and option exercises are excluded.

Jean Jacques Bienaime$492.7K
2,000 shares at $246.33 on 14 Aug 2026 · filed 18 Aug 2026

What if Ascendis Pharma A/S were worth as much as…

Open the what-if tool →

Gold $29.0T

$440,091.06

Per share 1,927× higher

Bitcoin $1.65T

$24,998.89

Per share 109× higher

Nvidia $5.72T

$86,865.08

Per share 380× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Ascendis Pharma A/S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Oct 2026. Read the methodology.